Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented InduPro in the transaction. InduPro, Inc., a biotechnology company announced an $85 million Series A financing co-led by The Column...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Rubedo Life Sciences on the transaction. Rubedo Life Sciences (Rubedo), a biopharmaceutical company, announced it closed a $40M Series A...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Assembly Bio on the transaction, and Ropes & Gray advised Gilead Sciences, Inc. Assembly Biosciences (Nasdaq: ASMB) and Gilead Sciences (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings A/S and Vida Ventures on the transaction. Avalyn Pharma Inc. announced the closing of an oversubscribed $175 million...
You must be a Standard 1 Year member to access this content.
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Switch Therapeutics on the transaction and launch. Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cajal Neuroscience on the deal. Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Udemy on the deal, while Simpson Thacher represented the underwriters. Udemy announced the pricing of its initial public offering of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sonder Holdings on the deal, while Weil advised Gores Metropoulos II, Inc. Sonder Holdings, a leading next-generation hospitality company that...
You must be a Standard 1 Year member to access this content.
